Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 630 Cr.
- Current Price ₹ 258
- High / Low ₹ 358 / 185
- Stock P/E 23.0
- Book Value ₹ 68.5
- Dividend Yield 0.00 %
- ROCE 22.8 %
- ROE 19.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 102% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 86.9 days to 166 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 67 | 56 | 72 | 76 | 100 | 129 | 157 | |
| 60 | 51 | 69 | 67 | 74 | 92 | 110 | |
| Operating Profit | 6 | 5 | 3 | 9 | 25 | 37 | 46 |
| OPM % | 9% | 9% | 4% | 12% | 25% | 29% | 30% |
| 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 | 10 |
| Profit before tax | 2 | 1 | -1 | 5 | 21 | 28 | 34 |
| Tax % | 39% | 45% | 93% | 23% | 24% | 26% | 25% |
| 1 | 1 | -1 | 4 | 16 | 21 | 25 | |
| EPS in Rs | 0.71 | 0.41 | -0.68 | 2.02 | 8.01 | 8.50 | 10.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 27% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 102% |
| 3 Years: | 89% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 22% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 25% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 5 | 3 | 7 | 21 | 96 | 143 |
| 15 | 14 | 15 | 17 | 29 | 33 | 39 | |
| 20 | 18 | 22 | 26 | 23 | 23 | 26 | |
| Total Liabilities | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
| 20 | 20 | 25 | 28 | 44 | 71 | 96 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 4 | 12 |
| Investments | 20 | 11 | 14 | 15 | 13 | 10 | 24 |
| 19 | 25 | 21 | 27 | 37 | 91 | 100 | |
| Total Assets | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -7 | 7 | 5 | 6 | -19 | 24 | ||
| 7 | -10 | -2 | -15 | -36 | -50 | ||
| -0 | -2 | -2 | 9 | 60 | 23 | ||
| Net Cash Flow | 0 | -4 | 1 | -1 | 6 | -3 | |
| Free Cash Flow | -7 | 1 | -0 | -13 | -57 | -17 | |
| CFO/OP | -121% | 274% | 61% | 37% | -31% | 70% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 76 | 53 | 77 | 80 | 88 | 103 |
| Inventory Days | 88 | 78 | 37 | 9 | 204 | ||
| Days Payable | 126 | 224 | 233 | 399 | 127 | ||
| Cash Conversion Cycle | 15 | -69 | -143 | -314 | 80 | 88 | 181 |
| Working Capital Days | -66 | -10 | -60 | -67 | -14 | 108 | 166 |
| ROCE % | 9% | 2% | 18% | 41% | 28% | 23% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Number of Collection Centers count |
|
||||
| Number of Diagnostic Centers & Labs count |
|||||
| Pathology Revenue Share % |
|||||
| Total Tests Conducted Lakhs |
|||||
| B2C (Retail Diagnostics) Revenue Share % |
|||||
| B2G (Government PPPs) Revenue Share % |
|||||
| Total Patient Count Lakhs |
|||||
| Number of Franchise Centers count |
|||||
Extracted by Screener AI
Documents
Announcements
-
Reply to Clarification- Financial results
8 July 2026 - Revised audited results for FY26 and H1 ended March 31, 2026 filed; NSE clarification and no fund deviation.
-
Disclosure under SEBI Takeover Regulations
6 July 2026 - Promoters declare no share encumbrance for FY ended March 31, 2026.
-
Price movement
2 July 2026 - Company clarified share price movement appears market-driven, with no undisclosed UPSI or material event.
-
General Updates
2 July 2026 - Chandan Healthcare clarifies recent share price movement is market-driven; no unpublished price-sensitive information disclosed.
-
Price movement
1 July 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …
Concalls
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025TranscriptPPT REC
-
Aug 2025TranscriptAI SummaryPPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points.